Development of chimeric antigen receptor engineered T-cell therapy for T-lineage malignancy

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Development of chimeric antigen receptor engineered T-cell therapy for T-lineage malignancy
Principal Investigator
Professor Tu, Wenwei   (Principal Investigator (PI))
Co-Investigator(s)
Professor Leung Wing Hang   (Co-Investigator)
Professor Wong Siu Lun   (Co-Investigator)
Professor Tsia Kevin Kin Man   (Co-Investigator)
Duration
36
Start Date
2023-01-01
Amount
1180218
Conference Title
Development of chimeric antigen receptor engineered T-cell therapy for T-lineage malignancy
Keywords
CAR-T, Hematologic malignancy, , ,
Discipline
CancerAllergy/Immunology
Panel
Biology and Medicine (M)
HKU Project Code
17103322
Grant Type
General Research Fund (GRF) 2022/23
Funding Year
2022
Status
On-going
Objectives
Refer to ES